AllianceBernstein’s China Biologic Products Holdings, Inc. CBPO Stock Holding History

AllianceBernstein’s Portfolio CBPO Stock Details CBPO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-3,391	Closed	-$275K	–	3206
2018 Q1	$275K	Sell	3,391 -281,929	-99%	-$22.8M	﹤0.01%	2729
2017 Q4	$22.5M	Sell	285,320 -144,019	-34%	-$12M	0.02%	741
2017 Q3	$39.6M	Sell	429,339 -52,174	-11%	-$5.01M	0.03%	550
2017 Q2	$54.5M	Sell	481,513 -74,012	-13%	-$8.27M	0.04%	460
2017 Q1	$55.6M	Buy	555,525 +180,970	+48%	+$19.3M	0.04%	444
2016 Q4	$40.3M	Buy	374,555 +160,458	+75%	+$18.8M	0.03%	512
2016 Q3	$26.7M	Buy	214,097 +193,302	+930%	+$22.8M	0.02%	612
2016 Q2	$2.21M	Buy	20,795 +2,729	+15%	+$317K	﹤0.01%	1619
2016 Q1	$2.07M	Buy	+18,066	New	+$2.12M	﹤0.01%	1588

Other funds holding CBPO

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

YCMGA

York Capital Management Global Advisors New York $87.8M AUM 45.55% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

HSBC Holdings London, United Kingdom $192B AUM 27.2% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

HIM

Hillhouse Investment Management Grand Cayman, Cayman Islands $3.13B AUM 7.29% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

AllianceBernstein's CBPO Position: Q2 2018 in Review

AllianceBernstein sold out of China Biologic Products Holdings, Inc. (CBPO) in Q2 2018, closing a stake of 3,391 shares — an estimated $275K sold.

AllianceBernstein first reported a position in CBPO in Q1 2016 and held it in 9 quarters. The position peaked at $55.6M in Q1 2017. 91 funds tracked by Wall St. Rank hold CBPO as of Q2 2018.

AllianceBernstein reported no remaining China Biologic Products Holdings, Inc. position as of Q2 2018 after selling out during the quarter.
AllianceBernstein sold 3,391 China Biologic Products Holdings, Inc. shares in Q2 2018, an estimated $275K.
AllianceBernstein first reported a position in China Biologic Products Holdings, Inc. in Q1 2016 and held it in 9 quarters.
AllianceBernstein's China Biologic Products Holdings, Inc. position peaked at $55.6M in Q1 2017.
91 funds tracked by Wall St. Rank held China Biologic Products Holdings, Inc. as of Q2 2018.

Based on AllianceBernstein's 13F filing for Q2 2018, filed 13 Aug 2018.